CO6990712A2 - Combinación farmacéutica antineuritica y composiciones - Google Patents
Combinación farmacéutica antineuritica y composicionesInfo
- Publication number
- CO6990712A2 CO6990712A2 CO14129791A CO14129791A CO6990712A2 CO 6990712 A2 CO6990712 A2 CO 6990712A2 CO 14129791 A CO14129791 A CO 14129791A CO 14129791 A CO14129791 A CO 14129791A CO 6990712 A2 CO6990712 A2 CO 6990712A2
- Authority
- CO
- Colombia
- Prior art keywords
- antineuritic
- compositions
- pharmaceutical combination
- pharmaceutical
- combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011014042A MX336979B (es) | 2011-12-16 | 2011-12-16 | Combinacion farmaceutica antineuritica y composiciones. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6990712A2 true CO6990712A2 (es) | 2014-07-10 |
Family
ID=48611941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO14129791A CO6990712A2 (es) | 2011-12-16 | 2014-06-16 | Combinación farmacéutica antineuritica y composiciones |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140323428A1 (es) |
| BR (1) | BR112014014774A2 (es) |
| CA (1) | CA2859487C (es) |
| CL (1) | CL2014001581A1 (es) |
| CO (1) | CO6990712A2 (es) |
| CR (1) | CR20140283A (es) |
| DO (1) | DOP2014000134A (es) |
| ES (1) | ES2525952B1 (es) |
| GT (1) | GT201400115A (es) |
| MX (1) | MX336979B (es) |
| NI (1) | NI201400058A (es) |
| PE (1) | PE20141688A1 (es) |
| PL (1) | PL231163B1 (es) |
| WO (1) | WO2013088410A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2826470B1 (en) * | 2013-07-19 | 2017-09-06 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of pregabalin |
| MX2014008336A (es) | 2014-07-07 | 2016-01-07 | Pptm Internat S A R L | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
| PE20251233A1 (es) | 2023-10-05 | 2025-04-29 | Laboratorios Silanes S A De C V | Tableta multiactivos en el tratamiento y control de dolor severo cronico y metodo de preparacion |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2592631A1 (en) * | 2003-12-29 | 2005-07-21 | Jason Mcdevitt | Compositions and methods to treat recurrent medical conditions |
| ES2416723T3 (es) * | 2007-10-09 | 2013-08-02 | Merck Patent Gmbh | Composiciones farmacéuticas que contienen benfotiamina y gabapentina |
| US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
-
2011
- 2011-12-16 MX MX2011014042A patent/MX336979B/es active IP Right Grant
-
2012
- 2012-12-14 PL PL409542A patent/PL231163B1/pl unknown
- 2012-12-14 ES ES201490063A patent/ES2525952B1/es not_active Expired - Fee Related
- 2012-12-14 CA CA2859487A patent/CA2859487C/en active Active
- 2012-12-14 BR BR112014014774A patent/BR112014014774A2/pt not_active Application Discontinuation
- 2012-12-14 US US14/365,988 patent/US20140323428A1/en not_active Abandoned
- 2012-12-14 PE PE2014000973A patent/PE20141688A1/es active IP Right Grant
- 2012-12-14 WO PCT/IB2012/057345 patent/WO2013088410A1/es not_active Ceased
-
2014
- 2014-06-16 DO DO2014000134A patent/DOP2014000134A/es unknown
- 2014-06-16 NI NI201400058A patent/NI201400058A/es unknown
- 2014-06-16 GT GT201400115A patent/GT201400115A/es unknown
- 2014-06-16 CR CR20140283A patent/CR20140283A/es unknown
- 2014-06-16 CO CO14129791A patent/CO6990712A2/es unknown
- 2014-06-16 CL CL2014001581A patent/CL2014001581A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014014774A2 (pt) | 2017-06-13 |
| DOP2014000134A (es) | 2014-07-31 |
| WO2013088410A1 (es) | 2013-06-20 |
| CR20140283A (es) | 2015-03-11 |
| PL231163B1 (pl) | 2019-01-31 |
| ES2525952A1 (es) | 2015-01-02 |
| MX336979B (es) | 2016-02-09 |
| CA2859487A1 (en) | 2013-06-20 |
| MX2011014042A (es) | 2013-06-17 |
| CL2014001581A1 (es) | 2014-09-26 |
| CA2859487C (en) | 2016-11-15 |
| ES2525952B1 (es) | 2015-10-05 |
| PL409542A1 (pl) | 2015-07-20 |
| US20140323428A1 (en) | 2014-10-30 |
| GT201400115A (es) | 2017-07-27 |
| PE20141688A1 (es) | 2014-12-03 |
| NI201400058A (es) | 2014-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600350B (it) | Composizioni farmaceutiche | |
| SMT201700008B (it) | Composizione farmaceutica | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
| DK3181128T3 (da) | Farmaceutisk nilotinib-sammensætning | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| LT2791160T (lt) | Modifikuotos mrnr sudėtys | |
| BR112013014644A2 (pt) | composição farmacêutica e complexo | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| BR112013023776A2 (pt) | composição e abertura vedada com selante | |
| EE201300005A (et) | Ravimkoostis | |
| EP2804599A4 (en) | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS | |
| HUE040370T2 (hu) | Gyógyszerkészítmények | |
| EP2552212A4 (en) | IMPROVED FORMULATION | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| EP2531023A4 (en) | IMPROVED FORMULATION | |
| DK2815752T3 (da) | Oral farmaceutisk sammensætning | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| BR112014015885A8 (pt) | preparação farmacêutica | |
| BR112013008074A2 (pt) | combinações farmacêuticas | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| BR112015002646A2 (pt) | composto e composição farmacêutica |